Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis

BMC Nephrology

Volumn 15, Issue 1, 2014, Pages

  Shah, Mitesh ^a   Jain, Arsh K ^b,c   Brunelli, Steven M ^d   Coca, Steven G ^e   Devereaux, Philip J ^f   James, Matthew T ^g   Luo, Jin ^c   Molnar, Amber O ^h   Mrkobrada, Marko ^b   Pannu, Neesh ⁱ   Parikh, Chirag R ^e   Paterson, Michael ^c,f   Shariff, Salimah ^d   Wald, Ron ^j   Walsh, Michael ^f   Whitlock, Richard ^f   Wijeysundera, Duminda N ^c,j   Garg, Amit X ^b,c,f,k  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MCMASTER UNIVERSITY   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

^h UNIVERSITY OF OTTAWA   (Canada)

ⁱ UNIVERSITY OF ALBERTA   (Canada)

^j UNIVERSITY OF TORONTO   (Canada)

^k LONDON HEALTH SCIENCES CENTRE   (Canada)

more..

Author keywords

Acute dialysis; Angiotensin converting enzyme inhibitor; Angiotensin receptor blocker; Major elective surgery

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIALYSIS; DRUG USE; ELECTIVE SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE COMPLICATION; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL MORTALITY; ACUTE KIDNEY INJURY; CANADA; CHEMICALLY INDUCED; CLINICAL TRIAL; EPIDEMIOLOGY; INCIDENCE; MORTALITY; MULTICENTER STUDY; PREMEDICATION; RENAL REPLACEMENT THERAPY; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ELECTIVE SURGICAL PROCEDURES; FEMALE; HUMANS; INCIDENCE; MALE; ONTARIO; PREMEDICATION; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84898548171     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-15-53     Document Type: Article

References (53)

1. Independent association between acute renal failure and mortality following cardiac surgery. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J, Am J Med 1998 104 343 348 10.1016/S0002-9343(98)00058-8 9576407 (Pubitemid 28211024)
2. Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Kheterpal S, Tremper KK, Englesbe MJ, O'Reilly M, Shanks AM, Fetterman DM, Rosenberg AL, Swartz RD, Anesthesiology 2007 107 892 902 10.1097/01.anes.0000290588.29668.38 18043057 (Pubitemid 350175671)
3. Statin use associates with a lower incidence of acute kidney injury after major elective surgery. Molnar AO, Coca SG, Devereaux PJ, Jain AK, Kitchlu A, Luo J, Parikh CR, Paterson JM, Siddiqui N, Wald R, Walsh M, Garg AX, J Am Soc Nephrol 2011 22 939 946 10.1681/ASN.2010050442 21493769
4. An estimation of the global volume of surgery: a modelling strategy based on available data. Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, Gawande AA, Lancet 2008 372 139 144 10.1016/S0140-6736(08)60878-8 18582931
5. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW, J Am Soc Nephrol 2005 16 3365 3370 10.1681/ASN.2004090740 16177006 (Pubitemid 46179340)
6. Determinants of postoperative acute kidney injury. Abelha FJ, Botelho M, Fernandes V, Barros H, Crit Care 2009 13 79 10.1186/cc7894 19463152
7. Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Kheterpal S, Tremper KK, Heung M, Rosenberg AL, Englesbe M, Shanks AM, Campbell DA Jr, Anesthesiology 2009 110 505 515 10.1097/ALN.0b013e3181979440 19212261
8. Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting. Miceli A, Capoun R, Fino C, Narayan P, Bryan AJ, Angelini GD, Caputo M, J Am Coll Cardiol 2009 54 1778 1784 10.1016/j.jacc.2009.07.008 19682819
9. Acute kidney injury associated with cardiac surgery. Rosner MH, Okusa MD, Clin J Am Soc Nephrol 2006 1 19 32 10.2215/CJN.01420406 17699187
10. Improving the identification of patients at risk of postoperative renal failure after cardiac surgery. Wijeysundera DN, Karkouti K, Beattie WS, Rao V, Ivanov J, Anesthesiology 2006 104 65 72 10.1097/00000542-200601000-00012 16394692
11. Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Arora P, Rajagopalam S, Ranjan R, Kolli H, Singh M, Venuto R, Lohr J, Clin J Am Soc Nephrol 2008 3 1266 1273 10.2215/CJN.05271107 18667735
12. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC, J Am Coll Cardiol 2008 51 1247 1254 10.1016/j.jacc.2007.10.063 18371553 (Pubitemid 351400891)
13. Renin-angiotensin system antagonists in the perioperative setting: clinical consequences and recommendations for practice. Auron M, Harte B, Kumar A, Michota F, Postgrad Med J 2011 87 472 481 10.1136/pgmj.2010.112987 21441164
14. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Tarkington LG, et al. Circulation 2007 116 418 e499 10.1161/CIRCULATIONAHA.107.185699 17901357
15. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery. Kheterpal S, Khodaparast O, Shanks A, O'Reilly M, Tremper KK, J Cardiothorac Vasc Anesth 2008 22 180 186 10.1053/j.jvca.2007.12.020 18375317 (Pubitemid 351424915)
16. Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period. Rosenman DJ, McDonald FS, Ebbert JO, Erwin PJ, LaBella M, Montori VM, J Hosp Med 2008 3 319 325 10.1002/jhm.323 18698608
17. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Levy AR, O'Brien BJ, Sellors C, Grootendorst P, Willison D, Can J Clin Pharmacol 2003 10 67 71 12879144 (Pubitemid 37028596)
18. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Lancet 2007 370 1453 1457 10.1016/S0140-6736(07)61602-X 18064739
19. Risk of acute kidney injury from oral acyclovir: a population-based study. Lam NN, Weir MA, Yao Z, Blake PG, Beyea MM, Gomes T, Gandhi S, Mamdani M, Wald R, Parikh CR, Hackam DG, Garg AX, Am J Kidney Dis 2013 61 723 729 10.1053/j.ajkd.2012.12.008 23312723
20. Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study. Patel AM, Shariff S, Bailey DG, Juurlink DN, Gandhi S, Mamdani M, Gomes T, Fleet J, Hwang YJ, Garg AX, Ann Intern Med 2013 158 869 876 10.7326/0003-4819-158-12-201306180-00004 23778904
21. Oral bisphosphonate use in the elderly is not associated with acute kidney injury. Shih AW, Weir MA, Clemens KK, Yao Z, Gomes T, Mamdani MM, Juurlink DN, Hird A, Hodsman A, Parikh CR, Wald R, Cadarette SM, Garg AX, Kidney Int 2012 82 903 908 10.1038/ki.2012.227 22695327
22. Secular trends in acute dialysis after elective major surgery-1995 to 2009. Siddiqui NF, Coca SG, Devereaux PJ, Jain AK, Li L, Luo J, Parikh CR, Paterson M, Philbrook HT, Wald R, Walsh M, Whitlock R, Garg AX, CMAJ 2012 184 1237 1245 10.1503/cmaj.110895 22733671
23. New fibrate use and acute renal outcomes in elderly adults: a population-based study. Zhao YY, Weir MA, Manno M, Cordy P, Gomes T, Hackam DG, Juurlink DN, Mamdani M, Moist L, Parikh CR, Paterson JM, Wald R, Yao Z, Garg AX, Ann Intern Med 2012 156 560 569 10.7326/0003-4819-156-8-201204170-00401 22508733
24. Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study. Gill SS, Anderson GM, Fischer HD, Bell CM, Li P, Normand SL, Rochon PA, Arch Intern Med 2009 169 867 873 10.1001/archinternmed.2009.43 19433698
25. A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Austin PC, Daly PA, Tu JV, Am Heart J 2002 144 290 296 10.1067/mhj.2002.123839 12177647 (Pubitemid 34879653)
26. Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in ontario, Canada, 1996 to 2007: a population-based study. Gershon AS, Wang C, Wilton AS, Raut R, To T, Arch Intern Med 2010 170 560 565 10.1001/archinternmed.2010.17 20308643
27. Quality of diagnosis and procedure coding in ICD-10 administrative data. Henderson T, Shepheard J, Sundararajan V, Med Care 2006 44 1011 1019 10.1097/01.mlr.0000228018.48783.34 17063133 (Pubitemid 44674033)
28. The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Kramer JR, Davila JA, Miller ED, Richardson P, Giordano TP, El-Serag HB, Aliment Pharmacol Ther 2008 27 274 282 17996017
29. Validity of stroke diagnosis on hospital discharge records in Saskatchewan, Canada: implications for stroke surveillance. Liu L, Reeder B, Shuaib A, Mazagri R, Cerebrovasc Dis 1999 9 224 230 10.1159/000015960 10393410 (Pubitemid 29308808)
30. Validating a case definition for chronic kidney disease using administrative data. Ronksley PE, Tonelli M, Quan H, Manns BJ, James MT, Clement FM, Samuel S, Quinn RR, Ravani P, Brar SS, Hemmelgarn BR, Nephrol Dial Transplant 2012 27 5 1826 1831 10.1093/ndt/gfr598 22015442
31. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT, BMC Med Res Methodol 2011 11 83 10.1186/1471-2288-11-83 21619668
32. Validity of international classification of diseases, ninth revision, clinical modification codes for acute renal failure. Waikar SS, Wald R, Chertow GM, J Am Soc Nephrol 2006 17 1688 1694 10.1681/ASN.2006010073 16641149 (Pubitemid 43794671)
33. Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison. Jha P, Deboer D, Sykora K, Naylor CD, J Am Coll Cardiol 1996 27 1335 1342 10.1016/0735-1097(96)00018-6 8626941 (Pubitemid 26153277)
34. Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. Mamdani M, Sykora K, Li P, Normand SL, Streiner DL, Austin PC, Rochon PA, Anderson GM, BMJ 2005 330 960 962 10.1136/bmj.330.7497.960 15845982 (Pubitemid 40592320)
35. Odds ratio, relative risk, absolute risk reduction, and the number needed to treat-which of these should we use? Schechtman E, Value Health 2002 5 431 436 10.1046/J.1524-4733.2002.55150.x 12201860
36. Using ACE, inhibitors appropriately. Bicket DP, Am Fam Physician 2002 66 461 468 12182524
37. Impact of preoperative angiotensin-converting enzyme inhibitor use on clinical outcomes after cardiac surgery. Ouzounian M, Buth KJ, Valeeva L, Morton CC, Hassan A, Ali IS, Ann Thorac Surg 2012 93 559 564 10.1016/j.athoracsur. 2011.10.058 22269723
38. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Austin PC, Grootendorst P, Anderson GM, Stat Med 2007 26 734 753 10.1002/sim.2580 16708349 (Pubitemid 46206593)
39. Indications for propensity scores and review of their use in pharmacoepidemiology. Glynn RJ, Schneeweiss S, Sturmer T, Basic Clin Pharmacol Toxicol 2006 98 253 259 10.1111/j.1742-7843.2006.pto-293.x 16611199
40. Preoperative renin-angiotensin system inhibitors protect renal function in aging patients undergoing cardiac surgery. Barodka V, Silvestry S, Zhao N, Jiao X, Whellan DJ, Diehl J, Sun JZ, J Surg Res 2011 167 63 e69 10.1016/j.jss.2009.11.702 20189597
41. Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting. Benedetto U, Sciarretta S, Roscitano A, Fiorani B, Refice S, Angeloni E, Sinatra R, Ann Thorac Surg 2008 86 1160 1165 10.1016/j.athoracsur.2008.06.018 18805152
42. The use of angiotensin-converting enzyme inhibitors in patients undergoing coronary artery bypass graft surgery. Lazar HL, Vascul Pharmacol 2005 42 119 123 10.1016/j.vph.2005.01.012 15792929 (Pubitemid 40417711)
43. Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery. Coca SG, Garg AX, Swaminathan M, Garwood S, Hong K, Thiessen-Philbrook H, Passik C, Koyner JL, Parikh CR, Nephrol Dial Transplant 2013 28 2787 2799 10.1093/ndt/gft405 24081864
44. The effects of preoperative therapy with angiotensin-converting enzyme inhibitors on clinical outcome after cardiovascular surgery. Rady MY, Ryan T, Chest 1998 114 487 494 10.1378/chest.114.2.487 9726735 (Pubitemid 28387528)
45. Effects of renin-angiotensin system inhibitors on the occurrence of acute kidney injury following off-pump coronary artery bypass grafting. Yoo YC, Youn YN, Shim JK, Kim JC, Kim NY, Kwak YL, Circ J 2010 74 1852 1858 10.1253/circj.CJ-10-0261 20631451
46. The chronic inhibition of angiotensin-converting enzyme impairs postoperative renal function. Cittanova ML, Zubicki A, Savu C, Montalvan C, Nefaa N, Zaier K, Riou B, Coriat P, Anesth Analg 2001 93 1111 1115 10.1097/00000539-200111000-00008 11682377 (Pubitemid 33020998)
47. Renin-angiotensin blockade is associated with increased mortality after vascular surgery. Railton CJ, Wolpin J, Lam-McCulloch J, Belo SE, Can J Anaesth 2010 57 736 744 10.1007/s12630-010-9330-4 20524103
48. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Crit Care 2004 8 204 R212 10.1186/cc2872 15312219
49. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: safety issues. Mangrum AJ, Bakris GL, Semin Nephrol 2004 24 168 175 10.1016/j.semnephrol.2003.11.001 15017529 (Pubitemid 38387858)
50. Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Schoolwerth AC, Sica DA, Ballermann BJ, Wilcox CS, Circulation 2001 104 1985 1991 10.1161/hc4101.096153 11602506 (Pubitemid 32983246)
51. The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease. Ahmed AK, Kamath NS, El KM, El Nahas AM, Nephrol Dial Transplant 2010 25 3977 3982 10.1093/ndt/gfp511 19820248
52. A new equation to estimate glomerular filtration rate. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, Ann Intern Med 2009 150 604 612 10.7326/0003-4819-150-9-200905050-00006 19414839
53. A simulation study of the number of events per variable in logistic regression analysis. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR, J Clin Epidemiol 1996 49 1373 1379 10.1016/S0895-4356(96)00236-3 8970487 (Pubitemid 27028925)